MoJo Biotechnology Information

MoJo biotechnology is a consulting partnership founded with the aim of helping guide biotechnology companies through the drug development process. We founded MoJo because we recognised that many smaller biotechnology companies don't have the capacity to take on all of the various aspects of drug development and don't know where to turn to get that help. Our aim is to work with your team to identify the critical activities and develop solutions that meet your timeline and budget. Michael West - Executive Director is a 25 year industry veteran with a broad range of experience in process development, formulation development and outsourcing manufacture. Michael worked at SmithKline Beecham Pharmaceutical (now GSK) in the USA before joining Alchemia Limited in 1997. While at Alchemia, Michael successfully managed the manufacture of fondaparinux sodium API and finished product. Fondaparinux is the lengthiest syntheses of a pharmaceutical product on the market and presented a number of significant challenges. Michael was also responsible for the sourcing of cytotoxic API's, the specification, formulation development and finished product manufacture for Alchemia's HA-Irinotecan product. Michael is a registered Patent & Trade Marks Attorney in Australia and New Zealand, and has managed several large portfolios of Intellectual Property.